CAN effectively inhibited NADPH oxidase and the production of ROS in fatty acid-treated pancreatic β-cells [47], and protected the kidney against hyperglycemia-associated oxidative stress in diabetic rats [48]. The gene discussed is FMO5; the disease is Hyperglycemia.